The National Institutes of Health (NIH) has awarded a two-year, $1.9m Phase II small business innovation research grant to Kensey Nash, to further evaluate the use of a bioadhesive surgical mesh for applications in tendon repair procedures.

The firm will develop and investigate the ability of its proprietary bioadhesive technology to improve sutured tendon repair, enhancing repair efficacy and patient outcomes.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Kensey Nash chief operating officer Doug Evans said the grant will allow the firm to explore new applications of adhesive technology along with other extracellular matrix, collagen, and polymer-based biomaterials to create new solutions for existing medical problems.

Kensey Nash manufactures cardiology, orthopaedic, sports medicine, spine, endovascular and general surgery products.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact